Alexander A. Jurisch

Associate, Seattle Office

Direct Dial: 206.521.6464
Fax: 206.386.5130

Practice Areas

Bar Admissions

  • Washington, 2018

Court Admissions

  • U.S. District Court, Eastern District of Washington, 2020
  • U.S. District Court, Western District of Washington, 2020
  • U.S. Patent and Trademark Office, 2019


  • Seattle University, School of Law - J.D., magna cum laude, 2017
  • Biola University - B.S., Biological Science, 2009

Practice Experience

Alexander Jurisch practices as an associate in Bullivant's Casualty Law Group. Before joining the firm, he worked as a Discovery Associate at a complex litigation law firm. There Alex worked on both class action and multidistrict litigation matters.

Alex received his J.D. from Seattle University School of Law where he graduated magna cum laude. During law school, Alex participated in moot court competitions and served as Associate Editor of the Seattle University Law Review and President of the Intellectual Property Law Society.

Combined with his legal training, Alex's scientific background, including a degree in Biological Science and more than five years working as a research scientist at a small biotech company, offers his clients a competitive advantage when complex medical, regulatory and legal issues intersect.

Professional and Civic Involvement

  • Alpha Sigma Nu (Member, 2016-Present)
  • Washington State Patent Law Association (Member, 2019-Present)
  • Seattle Intellectual Property Inn of Court (Member, 2017-2018)
  • American Chemical Society (Member, 2012-2015)

Awards and Honors

  • Recipient of the CALI Excellence for the Future Award (2017 — Evidence; 2017 — UCC Sales; 2016 — Patent Law)

Publications and Presentations

  • Author, "A Prescription for Biopharmaceutical Patents: A Cure for Inter Partes Review Ailments," 41 Seattle University Law Review 1211 (2018)
  • Speaker, "Rapid Development of a High-Producing CHO Transient Protein Production Method," Cell Culture Engineering XIV (2014)
  • Co-Author, "High Yield Transient Protein Production In CHO Cells," in BioProcess International (2015)
  • Co-Author, "Development of Chemically-Defined MDCK and VERO Culture Media for Cell-Based Vaccine Development and Manufacturing," in Vaccine Technology V (2014)
  • Co-Author, "Rapid Chemically-Defined Feed Media Development to Improve Simulated Cell Culture Processes" in BioProcess International (2011)

Outside the Firm

Outside the firm, Alex is kept very busy by his 3-year-old daughter and is expecting his first son in April 2020. In his dwindling spare time, Alex enjoys woodworking, trail running, reading, and playing board games.